Amitabha Ray

1.7k total citations
43 papers, 1.3k citations indexed

About

Amitabha Ray is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Amitabha Ray has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Amitabha Ray's work include Adipokines, Inflammation, and Metabolic Diseases (8 papers), Regulation of Appetite and Obesity (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). Amitabha Ray is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (8 papers), Regulation of Appetite and Obesity (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). Amitabha Ray collaborates with scholars based in United States, India and Jamaica. Amitabha Ray's co-authors include Margot P. Cleary, Katai J. Nkhata, Anjan Dhar, Michael E. Grossmann, Soner Doğan, William G. Gutheil, Animesh Dhar, Shrikant Anant, Gregory A. Reed and Olga P. Rogozina and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and European Journal of Cancer.

In The Last Decade

Amitabha Ray

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amitabha Ray United States 20 505 430 307 273 210 43 1.3k
Dimiter Avtanski United States 17 453 0.9× 205 0.5× 162 0.5× 167 0.6× 192 0.9× 51 1.1k
Naping Tang China 21 329 0.7× 235 0.5× 144 0.5× 124 0.5× 103 0.5× 44 1.2k
Meishu Xu United States 25 518 1.0× 268 0.6× 354 1.2× 139 0.5× 203 1.0× 50 1.4k
Yueh-Min Lin Taiwan 25 649 1.3× 290 0.7× 144 0.5× 184 0.7× 151 0.7× 62 1.4k
Donatella Vizza Italy 17 450 0.9× 143 0.3× 151 0.5× 187 0.7× 77 0.4× 31 947
Frank W. Kari United States 22 641 1.3× 341 0.8× 90 0.3× 370 1.4× 340 1.6× 45 1.5k
Shuichi Sakai United States 9 1.3k 2.5× 187 0.4× 507 1.7× 272 1.0× 752 3.6× 9 2.1k
Jinu‐Huang Su Taiwan 18 321 0.6× 182 0.4× 173 0.6× 105 0.4× 81 0.4× 33 836
Chiara Degirolamo Italy 16 882 1.7× 398 0.9× 380 1.2× 152 0.6× 239 1.1× 17 1.6k

Countries citing papers authored by Amitabha Ray

Since Specialization
Citations

This map shows the geographic impact of Amitabha Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amitabha Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amitabha Ray more than expected).

Fields of papers citing papers by Amitabha Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amitabha Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amitabha Ray. The network helps show where Amitabha Ray may publish in the future.

Co-authorship network of co-authors of Amitabha Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Amitabha Ray. A scholar is included among the top collaborators of Amitabha Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amitabha Ray. Amitabha Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ray, Amitabha, et al.. (2024). Insights into the Two Most Common Cancers of Primitive Gut-Derived Structures and Their Microbial Connections. Medicina. 60(9). 1515–1515. 1 indexed citations
2.
Ray, Amitabha, et al.. (2023). Infections and immunity: associations with obesity and related metabolic disorders. Journal of Pathology and Translational Medicine. 57(1). 28–42. 15 indexed citations
3.
Ray, Amitabha, et al.. (2023). Prognostic Significance of the Coagulation and Complement Systems in Critical COVID-19 Infection. SHILAP Revista de lepidopterología. 124(2). 77–93. 2 indexed citations
4.
5.
Ray, Amitabha, et al.. (2022). Evaluation of cancer awareness, cancer education, and prevention intervention techniques among university-level students in the United States and India. Journal of Education and Health Promotion. 11(1). 187–187. 1 indexed citations
6.
Haque, Inamul, Arnab Ghosh, Snigdha Banerjee, et al.. (2018). Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway. BMC Cancer. 18(1). 99–99. 45 indexed citations
7.
Ray, Amitabha. (2017). Tumor-linked HER2 expression: association with obesity and lipid-related microenvironment. Hormone Molecular Biology and Clinical Investigation. 32(3). 16 indexed citations
8.
Ray, Amitabha & Margot P. Cleary. (2017). The potential role of leptin in tumor invasion and metastasis. Cytokine & Growth Factor Reviews. 38. 80–97. 119 indexed citations
9.
Ray, Amitabha, et al.. (2016). Pathobiology of cancer and clinical biochemistry. 3(4). 187–201. 1 indexed citations
10.
Ray, Amitabha, et al.. (2015). Extracellular matrix in obesity – cancer interactions. Hormone Molecular Biology and Clinical Investigation. 22(2). 63–77. 13 indexed citations
11.
Hedau, Suresh, et al.. (2015). Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer. Journal of Cancer Research and Therapeutics. 11(1). 158–158. 26 indexed citations
12.
Bonorden, Melissa J.L., Michael E. Grossmann, Sarah Ewing, et al.. (2012). Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and Obesity. SHILAP Revista de lepidopterología. 2012. 1–13. 16 indexed citations
13.
Ray, Amitabha, et al.. (2012). Immunomodulatory effects of anti-estrogenic drugs. Acta Pharmaceutica. 62(2). 141–155. 20 indexed citations
14.
Ray, Amitabha & Margot P. Cleary. (2011). Obesity and breast cancer: A clinical biochemistry perspective. Clinical Biochemistry. 45(3). 189–197. 24 indexed citations
15.
Gutheil, William G., Gregory A. Reed, Amitabha Ray, Shrikant Anant, & Animesh Dhar. (2011). Crocetin: an Agent Derived from Saffron for Prevention and Therapy for Cancer. Current Pharmaceutical Biotechnology. 13(1). 173–179. 154 indexed citations
16.
Grossmann, Michael E., Amitabha Ray, Katai J. Nkhata, et al.. (2010). Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer and Metastasis Reviews. 29(4). 641–653. 143 indexed citations
17.
Hedau, Suresh, et al.. (2008). Sex hormone binding globulin in breast cancer. Indian Journal of Clinical Biochemistry. 23(3). 250–254. 10 indexed citations
18.
Ray, Amitabha, Katai J. Nkhata, Joseph P. Grande, & Margot P. Cleary. (2007). Diet-induced obesity and mammary tumor development in relation to estrogen receptor status. Cancer Letters. 253(2). 291–300. 29 indexed citations
19.
Ray, Amitabha, et al.. (2001). Serum lipids, lipoproteins and sex-hormone binding globulin in breast cancer. Indian Journal of Clinical Biochemistry. 16(1). 101–105. 2 indexed citations
20.
Bk, Sharma & Amitabha Ray. (2000). Breast and prostate cancer. Indian Journal of Clinical Biochemistry. 15(S1). 110–117. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026